NCT00882440
A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)
See it on ClinicalTrials.gov ↗576 people
33.5%
66.5%
193 womenmiddle line = equal numbers383 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 1992-01
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 21 Years – no maximum
- Average age
- mean 53.1 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 76% · Black / African American 13% · Hispanic / Latina 10.2% · Other 0.7%
Women left out
- No breastfeeding moms
Women who were breastfeeding could not join.
“Women of childbearing potential or who are breastfeeding”
- No women who could get pregnant
Most women roughly 15–50 years old were turned away.
“Women of childbearing potential or who are breastfeeding”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“History of chronic liver disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of myocardial infarction”
- No diabetes
Women with diabetes were turned away.
“Actively treated diabetes mellitis”
Study titles and rules are shown in their original English.